Cantor Fitzgerald reaffirmed their overweight rating on shares of Alector (NASDAQ:ALEC – Free Report) in a report issued on Tuesday morning, Benzinga reports. Separately, HC Wainwright reaffirmed a buy rating and set a $35.00 target price on shares of Alector in a research note on Thursday, June 20th. One research analyst has rated the stock […]

Cantor Fitzgerald reaffirmed their overweight rating on shares of Evolus (NASDAQ:EOLS – Free Report) in a report released on Monday, Benzinga reports. A number of other brokerages have also recently commented on EOLS. Needham & Company LLC restated a buy rating and set a $22.00 price objective on shares of Evolus in a research note […]

Cantor Fitzgerald reissued their neutral rating on shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) in a research note released on Monday, Benzinga reports. The firm currently has a $50.00 price objective on the biopharmaceutical company’s stock. Several other research analysts have also recently weighed in on the company. Barclays increased their price objective on […]

Cantor Fitzgerald reaffirmed their overweight rating on shares of Axsome Therapeutics (NASDAQ:AXSM – Free Report) in a report released on Monday, Benzinga reports. The brokerage currently has a $107.00 price target on the stock. Several other research firms also recently issued reports on AXSM. Bank of America raised Axsome Therapeutics from a neutral rating to […]